Sign In

henry copeland:

N-of-1 Clinical Trials: Removing the Hay to Find the Needle | Clinical Chemistry

an observed lack of universality in response to interventions and a greater focus on the individual with the emergence of precision medicine. A strong focus on the uniqueness of each individual has led to many discoveries in cancer diagnostics and drug efficacy and has prompted the US Food and Drug Administration to relabel numerous approved drugs to include pharmacogenomics information.
- clinchem.aaccjnls.org
hte wwb
FAQ | Blog | DMCA
© 2025 Pressflex LLC